申请人:NOVARTIS AG
                            
                            
                                公开号:WO2012120428A1
                            
                            
                                公开(公告)日:2012-09-13
                            
                            The present invention provides compounds of Formula I: (I) and related compounds as further described herein, and pharmaceutical compositions comprising these compounds. The invention further provides methods to use these compounds and compositions for treating disorders associated with undesired levels of Pirn kinase activity, including cancers and autoimmune disorders.